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Background: The aim of this study is to prospectively review the role of sentinel lymph node (SLN) biopsy in the
management of well differentiated thyroid carcinoma (WDTC), and to determine the efficacy of intraoperative
frozen section analysis at detecting SLN metastasis and central compartment involvement.
Methods: The SLN biopsy protocol using 1% methylene blue was performed in 300 patients undergoing
thyroidectomy for WDTC. A limited pretracheal central compartment neck dissection (CCND) was performed on all
patients. Lymph nodes staining blue were considered as SLN’s. Both frozen and permanent section analyses were
performed.
Results: SLN’s with metastasis were found in 14.3% (43/300) of cases. Of this, 11% (33/300) were positive on
intraoperative frozen section analysis. Frozen section results failed in predicting central compartment involvement
in 15 cases (5%) whereas central neck compartment involvement was missed in 5 cases (1.7%) when based on
permanent section results. On frozen section analysis, the sensitivity, specificity, positive predictive value and
negative predictive value (95% CI) of our SLN biopsy technique aiming to remove all disease from the central
compartment was 68.8% (53.6-80.9), 100% (98.1-100), 100% (87.0-100) and 94.4% (90.7-96.7) respectively with
P < 0.0001. On permanent section analysis, the values were 89.6% (76.6-96.1), 100% (98.1-100), 100% (89.8-100),
and 98.1% (95.3-99.3) with P < 0.0001.
Conclusion: This data series demonstrates that patients with WDTC have positive SLN’s in 14.3% of cases.
Moreover, when the SLN’s are negative for metastasis on frozen section, the central compartment was disease-free
in 94.4% of cases. Finally, this study shows that 23.3% of positive SLN’s were false negatives on intraoperative frozen
section. According to this data, SLN involvement is an accurate predictor of central compartment metastasis,
however surgeons should use caution when relying on intraoperative frozen section to determine whether to
perform a CCND.Introduction
Surgical management of patients with well differentiated
thyroid carcinoma (WDTC) remains controversial.
Though few will question the prognostic value of a
therapeutic neck dissection in the context of clinically
apparent nodal involvement, its role in the management
of occult cervical lymph node metastasis in well differen-
tiated thyroid carcinoma (WDTC) is the source of the
debate [1,2]. Inherent risks of permanent hypoparathyr-
oidism and vocal cord paresis have swayed against the* Correspondence: rkpayne@sympatico.ca
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reproduction in any medium, provided the oradoption of routine prophylactic central compartment
neck dissection (CCND) as standard management in the
context of occult metastasis [2-5]. However, many thy-
roid surgeons will argue in favour of prophylactic CCND
given an incidence of lymph node metastasis reported to
be as high as 90% and low rates of morbidity in experi-
enced hands [3,6-9]. Accordingly, an accurate SLNB
technique, if found to be effective, could prove to be a
valuable tool in the surgical management patients with
WDTC.
Sentinel lymph node biopsy has become a widely
adopted technique in the surgical management of mel-
anoma and early stage breast carcinoma. SLNB tech-
niques have also been proposed and are currently beingl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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cological malignancies [10], squamous cells carcinoma of
the head and neck [11,12], colorectal cancer [13] and
thyroid cancer [6,14]. The notion of sentinel lymph node
biopsy (SLNB) relies on the principle of orderly progres-
sion of metastasis within a lymphatic basin [15]. The
sentinel lymph node is defined as the first lymph node
draining a regional lymphatic basin from a primary
tumor. If the sentinel lymph node is found to be positive
for metastasis, there may have had metastatic spread to
the remainder of the lymphatic basin. An accurate SLNB
technique is of particular relevance for patients who are
found to be SLN negative, in which case the lymphatic
basin is considered to be disease-free and the patients,
in the case of WDTC, can be spared of CCND and its
associated morbidities.
A SLN technique involving frozen section evaluation
allows for a surgeon to assess the necessity for a CCND
at the time of the initial surgery and to avoid a
potentially more difficult reoperation of the central neck.
The aim of the current study is to prospectively review
the role of sentinel lymph node biopsy in the manage-
ment of well differentiated thyroid carcinoma, and to
determine the efficacy of intraoperative frozen section




This prospective study involves 300 patients who were
selected from the three adult teaching hospitals that are
part of McGill University Cancer Center in Montreal,
Quebec, Canada. Over a 3-year period, from June 2009
to June 2012, patients undergoing thyroid resection with
results suspicious for thyroid carcinoma on fine-needle
aspiration cytology (FNAC) were asked to participate in
this study. Exclusion criteria included medullary and
anaplastic thyroid cancer, benign thyroid disease, a his-
tory of previous thyroid surgery, pregnancy or activeFigure 1 Blue staining lymphatic channels appear moments after inje
central neck.breastfeeding, and clinically evident local or distant
metastasis. Written informed consent was obtained
from all candidates as per the requirements of McGill
University’s ethics review board.
Surgical technique
Following intra-operative exposure of the thyroid nodule
by lateralization of the strap muscles, a 27 gauge tuber-
culin syringe was used to inject a total of 0.2 cc’s of 1%
methylene blue dye peritumorally in all four quadrants
within the thyroid parenchyma. Following the injection,
1 minute was allotted for the diffusion of the dye.
Lymphatic channels staining blue (Figure 1) were traced
into the central neck compartment. Lymph nodes stain-
ing blue, if present, were considered SLN’s and were
harvested. Both frozen and permanent section analyses
were performed. No attempt was made to identify SLN’s
outside of the central neck compartment. The operative
procedure was then performed as planned and followed
by a limited pretracheal CCND independantly of frozen
section results. The study includes all patients with con-
firmed thyroid carcinoma on final pathological results.
Results
Three hundred (N = 300) patients were found to meet
the inclusion criteria for the study and had confirmed
thyroid carcinoma on final pathological study. The study
includes 256 women and 44 men with an average age of
48.9 years (SD 13.6). The distribution of the final thyroid
pathology is found in Table 1.
Altogether, SLN’s with metastasis were found in 14.3%
(43/300) of cases. Of this, 11% (33/300) were positive on
intraoperative frozen section analysis. Frozen section
results failed in predicting central compartment involve-
ment in 15 cases (5%) whereas central neck compart-
ment involvement was missed in 5 cases (1.7%) when
based on permanent section results. On frozen section
analysis (Table 2), the sensitivity, specificity, positive pre-
dictive value and negative predictive value (95% CI) ofction of the methylene dye and lead towards the SLN within the
Table 1 Distribution of final thyroid gland pathology
Final pathology N° of patients
Conclusive fnac results Papillary thyroid carcinoma 115
Papillary microcarcinoma 19
Follicular carcinoma* 4
Inconclusive fnac results Papillary thyroid carcinoma 75
Papillary microcarcinoma 76
Follicular carcinoma 11
*These patients had a preoperative fine needle aspiration cytology result
positive for HBME; and were pre-operatively considered to be a follicular
variant of a papillary carcinoma.
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from the central compartment was 68.8% (53.6-80.9),
100% (98.1-100), 100% (87.0-100) and 94.4% (90.7-96.7)
respectively with P < 0.0001. On permanent section ana-
lysis (Table 3), the values were 89.6% (76.6-96.1), 100%
(98.1-100), 100% (89.8-100), and 98.1% (95.3; 99.3) with
P < 0.0001.
Patients were then further separated into 2 categories
(Table 4): those with pre-operative FNAC that confirmed
papillary thyroid carcinoma and those with inconclusive
FNAC results, but final pathological findings demon-
strating carcinoma of the thyroid gland. FNAC results
were considered inconclusive when results indicated
follicular lesions with various levels of atypia, hurthle
cell lesions, and samples insufficient for diagnosis.Discussion
Keleman et al., in a study looking at 17 cases, were the
first to report the use of SLN biopsy in the context of
thyroid carcinoma [16]. However, in both this study and
a similar following study by Haigh and Giuliano, a con-
trol neck dissection was not carried out and, as such, did
not allow for the calculation of false negative rates,
PPV’s, or NPV’s [17]. A control lateral and central neck
dissection was performed in a study by Fukui et al. [18].
A SLN was found in 21 of the 22 patients, and predic-
tion of disease status was accurate 19 of the 21 patients
(90%). Finally, in a more recent study Cunningham et al.Table 2 Fisher exact contingency table- frozen
section analysis
(+) Metastasis (−) Metastasis Total
(+)SLN 33 0 33 PPV = 100.0%
(−) SLN 15 252 267 NPV = 94.4%
Total 48 252 300
Sensitivity = 68.8% Specificity = 100.0%
(+)SLN sentinel lymph node positive for metastasis; (-)SLN sentinel lymph node
negative for metastasis; (+)Metastasis Central compartment sample involved
with metastasis;
(-) Metastasis Central compartment sample negative for metastasis.performed a retrospective review of 211 patients and
concluded that SLNB is a feasible and safe technique
that may allow to identify patients who can benefit from
a CCND [19].
The clinical utility of a proper SLN technique with fro-
zen section relies on its ability to predict with both high
sensitivity and specificity potential metastatic involve-
ment of a lymphatic basin. In this study, we aimed to as-
sess not only the value of such a technique for patients
undergoing surgery for cancer of the thyroid gland, but
an effort was also made to evaluate the utility of this
technique within subgroups of patients.
Global study
First, a global analysis of all patients meeting the inclu-
sion criteria was performed. Results revealed a signifi-
cant false-negative rate of 31.3% and a 20.8% gap
between sensitivity results based on frozen and
permanent section analyses. Given the importance of a
high sensitivity in identifying patients who can be
spared of a central neck dissection, all 15 false-
negative cases are herein duly reviewed in an attempt
to explain the potential shortcomings of our SLN tech-
nique (Figure 2).
Based on this data series, the main contributor to the
false-negative cases involves an increased difficulty in
diagnosing metastasis to a lymph node on frozen section
as compared to permanent section. Of the 15 false nega-
tive cases in which the SLN specimen was judged to be
metastasis-free at the time of frozen section, 10 cases
were revealed to harbor metastasis upon permanent sec-
tion. Though 3 of these were explained by inadequate
specimen handling, and frank misinterpretation of the
histological section; the 7 remaining instances were re-
flective of the inherent limitations of a frozen section
study. However, it is of note that in 9 of these 10 cases,
the sentinel lymph node was the only location within the
central neck that was addressed to which there had been
metastasis. In other words, despite not being able to
demonstrate metastatic involvement at the time of the
operation, our SLN technique was in and of itself effect-
ive in rendering a disease-free neck compartment in 9 ofTable 3 Fisher exact contingency table- permanent
section analysis
(+) Metastasis (−) Metastasis Total
(+)SLN 43 0 43 PPV = 100.0%
(−) SLN 5 252 257 NPV = 98.1%
Total 48 252 300
Sensitivity = 89.6% Specificity = 100.0%
(+)SLN sentinel lymph node positive for metastasis; (-)SLN sentinel lymph node
negative for metastasis; (+)Metastasis Central compartment sample involved
with metastasis;
(-) Metastasis Central compartment sample negative for metastasis.
Table 4 Frozen and permanent section analyses of different patient subgroups
Type of analysis N sensitivity 95% CI specificity 95% CI PPV 95% CI NPV 95% CI p-value
FS sum 300 68.8 53.6-80.9 100 98.1-100 100 87.0-100 94.4 90.7-96.7 <0.0001
PS sum 300 89.6 76.6-96.1 100 98.1-100 100 89.8-100 98.1 95.3-99.3 <0.0001
FS, fnac (+) 138 70.7 54.3-83.4 100 95.3-100 100 85.4-100 89.0 81.2-93.9 <0.0001
PS, fnac (+) 138 90.2 75.9-96.8 100 95.3-100 100 88.3-100 96.0 89.6-98.7 <0.0001
FS, fnac (−) 162 57.1 20.2-88.2 100 97.0-100 100 39.6-100 98.1 94.1-99.5 <0.0001
PS, fnac (−) 162 85.7 42.0-99.2 100 97.0-100 100 51.7-100 99.4 95.9-100 <0.0001
FS frozen section, PS permanent section, sum summary analysis, fnac (+), conclusive pre-operative fine-needle aspiration cytology, fnac (−) inconclusive fine-needle
aspiration cytology, CI confidence interval, PPV positive predictive value, NPV negative predictive value.
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Presumably, these cases could be considered as early
metastases involving minute portions of the SLN, which
would predispose to sampling errors at the time of fro-
zen section.
An additional short-coming of our method is most ap-
preciable when observing the 5 false-negative cases on
permanent section analysis. In fact, merely 2 of these
represented cases in which the SLN was disease-free
while there had been metastatic spread to the central
neck compartment. In the 3 additional cases, the speci-
men sent for frozen section did not contain a SLN. In
fact, had we rejected these from the analysis, our SNL
technique would have been associated with a sensitivity
of 95.6% on permanent section analysis and 73.3% on
frozen section analysis.
Altogether, a summary analysis of all patients included
in the study allows us to conclude that our SLN tech-
nique, serving as a surrogate diagnostic tool for central
neck compartment metastatic involvement, is 73.3% sen-
sitive and 100% specific based on frozen section results
when a SLN is found. Moreover, the apparent low sensi-
tivity is a direct result of limitations a frozen section
study. Nevertheless, the SLN technique when considered
as treatment arm for patients with central neck compart-
ment metastasis and a detectable SLN is 93.3% (42/45)
efficacious in providing a disease-free neck for the area
that was addressed. In this case, the non-concordance
between the failure rate of our technique (6.7%) and itsFigure 2 Review of false-negative cases.associated false-negative rate is accounted for by the 9
false-negative cases in which the SLN was the only site
of metastasis.
Subgroup study
That said, further subgroup analysis was performed in
order to assess for confounding. On one hand, the ana-
lysis of the positive FNAC subgroup reveals sensitivity
and specificity results that are slightly stronger than the
global assessment (Table 4), and an associated efficacy of
92.3% (36/39) in patients with a detectable SLN. One
hundred thirty eight patients were included in this
category, of which 41 were found to have metastatic in-
volvement of the central neck lymphatic basin. There
were 12 false negative results on frozen section analysis,
5 instances in which the central compartment was not
rendered disease-free following our SLN technique, but
only 2 of these cases had detectable SLN’s in the in the
SLN specimen recovered.
On the other hand, the analysis of the subgroup with
inconclusive pre-operative FNAC results reveals much
weaker results than those determined in the global study
and the FNAC (+) subgroup. Of the total 162 patients in
this category, merely 7 were found to have metastatic in-
volvement of the central compartment, with 3 false-
negatives resulting in a 57.1% sensitivity value and a very
wide 95% CI (Figure 2). Thus, it would seem that the
utility of a SLNB technique in patients without a
conclusive pre-operative FNAC result would be highly
questionable.
Conclusion
This data series demonstrates that patients with WDTC
have positive SLN’s in 14.3% of cases. This study also
shows that 23.3% of positive SLN’s were false negatives
on intraoperative frozen section. Nevertheless, when the
SLN’s are negative for metastasis on frozen section, the
central compartment was disease-free in 94.4% of cases.
Accordingly, SLN involvement is an accurate predictor
of central compartment metastasis; however surgeons
should use caution when relying on intraoperative frozen
section to determine whether to perform a CCND. Best
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pre-operative FNAC (demonstrating or highly suspicious
for carcinoma of the thyroid gland) and those for which
the SLN specimen contained a detectable lymph node.
Despite a sensitivity of 70.7% in this category of patients,
our SLN technique was associated with a 92.3% efficacy
in rendering a disease-free central neck in patients with
metastatic involvement and a detectable SLN.
For many surgeons in our thyroid cancer center, the
sentinel lymph node technique has become a mainstay
of treatment in patients undergoing thyroidectomy for
suspected thyroid cancer. It has proven to be an effective
tool in reflecting cancer status of the central neck and it
is the only tool available that may help avoid unneces-
sary neck dissections and its associated complications in
patients in whom the status of the lymphatic basin is un-
known.
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